AG˹ٷ

STOCK TITAN

WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Tags
buybacks

WuXi AppTec (WUXAY) has completed significant share repurchase and acquisition activities in Q2 2025. The company executed an RMB1.0 billion A-share repurchase program, buying back 15,775,377 A-shares at RMB63.39 per share (0.55% of total shares) between April 18 and June 20, 2025, which were subsequently cancelled on June 24.

Additionally, the company acquired HKD2.5 billion worth of H-shares (34,092,975 shares, 1.19% of total shares) through its 2025 H Share Award and Trust Scheme. The H-share acquisition is tied to revenue targets, with HKD1.5 billion in shares to be granted if 2025 revenue reaches RMB42.0 billion, and an additional HKD1.0 billion if revenue hits RMB43.0 billion.

WuXi AppTec (WUXAY) ha completato importanti operazioni di riacquisto di azioni e acquisizioni nel secondo trimestre del 2025. La società ha realizzato un programma di riacquisto di azioni A per un valore di 1,0 miliardi di RMB, acquistando 15.775.377 azioni A a 63,39 RMB ciascuna (0,55% del totale delle azioni) tra il 18 aprile e il 20 giugno 2025, azioni che sono state successivamente annullate il 24 giugno.

Inoltre, l'azienda ha acquisito azioni H per un valore di 2,5 miliardi di HKD (34.092.975 azioni, 1,19% del totale) tramite il suo Piano di Assegnazione e Trust per le Azioni H del 2025. L'acquisizione delle azioni H è legata a obiettivi di fatturato, con 1,5 miliardi di HKD in azioni da assegnare se il fatturato 2025 raggiunge i 42,0 miliardi di RMB, e ulteriori 1,0 miliardo di HKD se il fatturato tocca i 43,0 miliardi di RMB.

WuXi AppTec (WUXAY) completó importantes actividades de recompra de acciones y adquisiciones en el segundo trimestre de 2025. La empresa ejecutó un programa de recompra de acciones A por valor de 1.000 millones de RMB, recomprando 15.775.377 acciones A a 63,39 RMB por acción (0,55% del total de acciones) entre el 18 de abril y el 20 de junio de 2025, que fueron posteriormente canceladas el 24 de junio.

Además, la compañía adquirió acciones H por valor de 2.500 millones de HKD (34.092.975 acciones, 1,19% del total) mediante su Plan de Premios y Fideicomiso de Acciones H 2025. La adquisición de acciones H está vinculada a objetivos de ingresos, con 1.500 millones de HKD en acciones que se otorgarán si los ingresos de 2025 alcanzan los 42.000 millones de RMB, y otros 1.000 millones de HKD si los ingresos llegan a 43.000 millones de RMB.

WuXi AppTec (WUXAY)� 2025� 2분기� 중요� 자사� 매입 � 인수 활동� 완료했습니다. 회사� 10� 위안 규모� A� 자사� 매입 프로그램� 실행하여, 2025� 4� 18일부� 6� 20일까지 주당 63.39 위안� A� 15,775,377�(� 주식� 0.55%)� 매입했으�, � 주식들은 6� 24일에 취소되었습니�.

또한, 회사� 2025� H� 수여 � 신탁 계획� 통해 25� 홍콩달러 상당� H�(34,092,975�, � 주식� 1.19%)� 인수했습니다. H� 인수� 매출 목표와 연동되어 있으�, 2025� 매출� 420� 위안� 도달하면 15� 홍콩달러 상당� 주식� 부�되고, 매출� 430� 위안� 도달하면 추가� 10� 홍콩달러 상당� 주식� 부�됩니�.

WuXi AppTec (WUXAY) a réalisé d'importantes opérations de rachat d'actions et d'acquisitions au deuxième trimestre 2025. La société a mis en œuvre un programme de rachat d'actions A d'une valeur de 1,0 milliard de RMB, rachetant 15 775 377 actions A à 63,39 RMB par action (0,55 % du total des actions) entre le 18 avril et le 20 juin 2025, actions qui ont ensuite été annulées le 24 juin.

De plus, la société a acquis des actions H pour une valeur de 2,5 milliards de HKD (34 092 975 actions, soit 1,19 % du total) via son Plan d'attribution et de fiducie d'actions H 2025. L'acquisition des actions H est liée à des objectifs de chiffre d'affaires, avec 1,5 milliard de HKD en actions à attribuer si le chiffre d'affaires 2025 atteint 42,0 milliards de RMB, et un supplément de 1,0 milliard de HKD si le chiffre d'affaires atteint 43,0 milliards de RMB.

WuXi AppTec (WUXAY) hat im zweiten Quartal 2025 bedeutende Aktienrückkauf- und Akquisitionstätigkeiten abgeschlossen. Das Unternehmen führte ein Aktienrückkaufprogramm für A-Aktien im Wert von 1,0 Milliarden RMB durch und kaufte zwischen dem 18. April und 20. Juni 2025 insgesamt 15.775.377 A-Aktien zu je 63,39 RMB zurück (0,55 % der Gesamtaktien), die anschließend am 24. Juni storniert wurden.

Zusätzlich erwarb das Unternehmen H-Aktien im Wert von 2,5 Milliarden HKD (34.092.975 Aktien, 1,19 % der Gesamtaktien) über sein H-Share-Award- und Trust-Programm 2025. Der Erwerb der H-Aktien ist an Umsatzziele gebunden, wobei H-Aktien im Wert von 1,5 Milliarden HKD vergeben werden, wenn der Umsatz 2025 42,0 Milliarden RMB erreicht, und weitere 1,0 Milliarde HKD, wenn der Umsatz 43,0 Milliarden RMB erreicht.

Positive
  • Completed RMB1.0 billion A-share repurchase program to enhance shareholder value
  • Acquired HKD2.5 billion worth of H-shares for employee retention without diluting existing shareholders
  • H-share awards are performance-linked to ambitious revenue targets of RMB42-43 billion for 2025
Negative
  • Significant cash outlay of approximately RMB3.1 billion total for share programs
  • Share acquisitions represent relatively small percentage of total shares (combined 1.74%)

SHANGHAI, July 7, 2025 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock codes: 603259.SH/2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, recently provided updates to investors on the status of its A-share repurchase and H-share acquisition activities in Q2 2025.

The Company repurchased and cancelled RMB1.0 billion worth of A-share to enhance shareholder value, and instructed the trustee (the "Scheme Trustee") of its 2025 H Share Award and Trust Scheme to acquire HKD2.5 billion worth of H-share for the purpose of attracting and retaining highly talented employees.

Here is a full update on both programs:

Update on A-Share Repurchase and Cancellation:

  • On April 8, 2025, the Company's Board of Directors approved an RMB1.0 billion A-share repurchase and cancellation program. It took this action to uphold the Company's value and protect the interests of shareholders.
  • From April 18, 2025 to June 20, 2025, WuXi AppTec spent RMB1.0 billion (exclusive of transaction fees) to buy an aggregate of 15,775,377 A Shares (representing approximately 0.55% of the Company's total issued share capital as of June 23, 2025) at an average price of RMB63.39 per share.
  • On June 24, 2025, WuXi AppTec completed cancellation of all A Shares repurchased under this program.
  • For more information, please refer to the Company's relevant announcement:
    • June 23, 2025: .

Update on H-Share Acquisition:

  • As of June 27, 2025, the Company instructed the Scheme Trustee to complete the acquisition of HKD2.5 billion worth of H Shares through on-market transactions for the purpose of the 2025 H Share Award and Trust Scheme, with an aggregate of 34,092,975 H shares acquired (representing approximately 1.19% of the Company's total issued share capital as of June 30, 2025), and will not result in dilution to existing shareholders.
  • These acquired H shares will be used to continuously attract and retain top talents, strengthen the collective capabilities of management team, and enhance the resilience of the Company's business operations and management.
  • According to the 2025 H Share Award and Trust Scheme:
    • No more than HKD1.5 billion worth of H shares will be granted to the selected employees upon the Company's 2025 revenue achieving at least RMB42.0 billion.
    • An additional HKD1.0 billion worth of H shares (and thus a total of HKD2.5 billion worth of H shares) will be granted to the selected employees upon the Company's 2025 revenue achieving at least RMB43.0 billion.
  • For more information, please refer to the Company's relevant announcements:
    • June 13, 2025: .
    • June 30, 2025: .

About WuXi AppTec

WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer an integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside nearly 6,000 partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time. Learn more at .

Cision View original content:

SOURCE WuXi AppTec

FAQ

How many shares did WuXi AppTec (WUXAY) repurchase in Q2 2025?

WuXi AppTec repurchased 15,775,377 A-shares (0.55% of total shares) at an average price of RMB63.39 per share, totaling RMB1.0 billion.

What are the revenue targets for WuXi AppTec's 2025 H Share Award scheme?

The company will grant HKD1.5 billion in H-shares if 2025 revenue reaches RMB42.0 billion, and an additional HKD1.0 billion if revenue reaches RMB43.0 billion.

How many H-shares did WuXi AppTec acquire for its employee trust scheme?

The company acquired 34,092,975 H-shares (1.19% of total shares) worth HKD2.5 billion through its 2025 H Share Award and Trust Scheme.

When did WuXi AppTec complete the cancellation of repurchased A-shares?

WuXi AppTec completed the cancellation of all repurchased A-shares on June 24, 2025.

Will WuXi AppTec's H-share acquisition dilute existing shareholders?

No, the H-share acquisition will not result in dilution to existing shareholders as these shares were purchased through on-market transactions.
Wuxi Apptec

OTC:WUXAY

WUXAY Rankings

WUXAY Latest News

WUXAY Stock Data

27.85B
2.50B
Diagnostics & Research
Healthcare
China
Shanghai